Literature DB >> 14616089

Anthrax lethal factor-cleavage products of MAPK (mitogen-activated protein kinase) kinases exhibit reduced binding to their cognate MAPKs.

A Jane Bardwell1, Mahsa Abdollahi, Lee Bardwell.   

Abstract

Anthrax lethal toxin is the major cause of death in systemic anthrax. Lethal toxin consists of two proteins: protective antigen and LF (lethal factor). Protective antigen binds to a cell-surface receptor and transports LF into the cytosol. LF is a metalloprotease that targets MKKs [MAPK (mitogen-activated protein kinase) kinases]/MEKs [MAPK/ERK (extracellular-signal-regulated kinase) kinases], cleaving them to remove a small N-terminal stretch but leaving the bulk of the protein, including the protein kinase domain, intact. LF-mediated cleavage of MEK1 and MKK6 has been shown to inhibit signalling through their cognate MAPK pathways. However, the precise mechanism by which this proteolytic cleavage inhibits signal transmission has been unclear. Here we show that the C-terminal LF-cleavage products of MEK1, MEK2, MKK3, MKK4, MKK6 and MKK7 are impaired in their ability to bind to their MAPK substrates, suggesting a common mechanism for the LF-induced inhibition of signalling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14616089      PMCID: PMC1223970          DOI: 10.1042/BJ20031382

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  45 in total

1.  A conserved docking site in MEKs mediates high-affinity binding to MAP kinases and cooperates with a scaffold protein to enhance signal transmission.

Authors:  A J Bardwell; L J Flatauer; K Matsukuma; J Thorner; L Bardwell
Journal:  J Biol Chem       Date:  2000-12-28       Impact factor: 5.157

Review 2.  Mammalian MAP kinase signalling cascades.

Authors:  L Chang; M Karin
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

Review 3.  Signal transduction by the JNK group of MAP kinases.

Authors:  R J Davis
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 4.  Docking domains and substrate-specificity determination for MAP kinases.

Authors:  A D Sharrocks; S H Yang; A Galanis
Journal:  Trends Biochem Sci       Date:  2000-09       Impact factor: 13.807

5.  Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor.

Authors:  G Vitale; L Bernardi; G Napolitani; M Mock; C Montecucco
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

6.  Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha.

Authors:  R Pellizzari; C Guidi-Rontani; G Vitale; M Mock; C Montecucco
Journal:  FEBS Lett       Date:  1999-11-26       Impact factor: 4.124

7.  Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways.

Authors:  N S Duesbery; J Resau; C P Webb; S Koochekpour; H M Koo; S H Leppla; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

8.  Molecular determinants that mediate selective activation of p38 MAP kinase isoforms.

Authors:  H Enslen; D M Brancho; R J Davis
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

9.  Tumor cell-selective cytotoxicity of matrix metalloproteinase-activated anthrax toxin.

Authors:  S Liu; S Netzel-Arnett; H Birkedal-Hansen; S H Leppla
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

10.  A docking site in MKK4 mediates high affinity binding to JNK MAPKs and competes with similar docking sites in JNK substrates.

Authors:  David T Ho; A Jane Bardwell; Mahsa Abdollahi; Lee Bardwell
Journal:  J Biol Chem       Date:  2003-06-03       Impact factor: 5.157

View more
  43 in total

1.  Contribution of lethal toxin and edema toxin to the pathogenesis of anthrax meningitis.

Authors:  Celia M Ebrahimi; Tamsin R Sheen; Christian W Renken; Roberta A Gottlieb; Kelly S Doran
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

2.  Two hydrophobic residues can determine the specificity of mitogen-activated protein kinase docking interactions.

Authors:  A Jane Bardwell; Lee Bardwell
Journal:  J Biol Chem       Date:  2015-09-14       Impact factor: 5.157

Review 3.  Analysis of mitogen-activated protein kinase activation and interactions with regulators and substrates.

Authors:  Lee Bardwell; Kandarp Shah
Journal:  Methods       Date:  2006-11       Impact factor: 3.608

4.  Mechanisms of MAPK signalling specificity.

Authors:  L Bardwell
Journal:  Biochem Soc Trans       Date:  2006-11       Impact factor: 5.407

5.  Intrinsic fluctuations, robustness, and tunability in signaling cycles.

Authors:  Joseph Levine; Hao Yuan Kueh; Leonid Mirny
Journal:  Biophys J       Date:  2007-03-30       Impact factor: 4.033

6.  Selectivity of docking sites in MAPK kinases.

Authors:  A Jane Bardwell; Erlynn Frankson; Lee Bardwell
Journal:  J Biol Chem       Date:  2009-02-05       Impact factor: 5.157

7.  Toxoplasma gondii rhoptry discharge correlates with activation of the early growth response 2 host cell transcription factor.

Authors:  Eric D Phelps; Kristin R Sweeney; Ira J Blader
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

8.  Surviving the passage: Non-canonical stromal targeting of an Arabidopsis mitogen-activated protein kinase kinase.

Authors:  Marcus A Samuel; Balbir K Chaal; Greg Lampard; Beverley R Green; Brian E Ellis
Journal:  Plant Signal Behav       Date:  2008-01

9.  Highly predictive support vector machine (SVM) models for anthrax toxin lethal factor (LF) inhibitors.

Authors:  Xia Zhang; Elizabeth Ambrose Amin
Journal:  J Mol Graph Model       Date:  2015-11-17       Impact factor: 2.518

10.  Interacting JNK-docking sites in MKK7 promote binding and activation of JNK mitogen-activated protein kinases.

Authors:  David T Ho; A Jane Bardwell; Seema Grewal; Corey Iverson; Lee Bardwell
Journal:  J Biol Chem       Date:  2006-03-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.